246 related articles for article (PubMed ID: 25314246)
1. Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection.
Page EE; Greathead L; Metcalf R; Clark SA; Hart M; Fuchs D; Pantelidis P; Gotch F; Pozniak A; Nelson M; Boasso A; Gazzard B; Kelleher P
J Acquir Immune Defic Syndr; 2014 Nov; 67(3):227-35. PubMed ID: 25314246
[TBL] [Abstract][Full Text] [Related]
2. The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.
Chevalier MF; Petitjean G; Dunyach-Rémy C; Didier C; Girard PM; Manea ME; Campa P; Meyer L; Rouzioux C; Lavigne JP; Barré-Sinoussi F; Scott-Algara D; Weiss L
PLoS Pathog; 2013; 9(6):e1003453. PubMed ID: 23818854
[TBL] [Abstract][Full Text] [Related]
3. Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa.
Azadegan-Dehkordi F; Shirzad H; Ahmadi R; Bashash D; Abdollahpour-Alitappeh M; Luzza F; Larussa T; Nahid-Samiei M; Rahimian G; Shafigh MH; Bagheri N
Hum Immunol; 2021 Jan; 82(1):46-53. PubMed ID: 33127161
[TBL] [Abstract][Full Text] [Related]
4. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
5. The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation.
Van de Wijer L; van der Heijden WA; Ter Horst R; Jaeger M; Trypsteen W; Rutsaert S; van Cranenbroek B; van Rijssen E; Joosten I; Joosten L; Vandekerckhove L; Schoofs T; van Lunzen J; Netea MG; Koenen HJPM; van der Ven AJAM; de Mast Q
Front Immunol; 2021; 12():661990. PubMed ID: 33953724
[TBL] [Abstract][Full Text] [Related]
6. Emergence of a distinct HIV-specific IL-10-producing CD8+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection.
Clutton G; Yang H; Hancock G; Sande N; Holloway C; Angus B; von Delft A; Barnes E; Borrow P; Pellegrino P; Williams I; McMichael A; Dorrell L
Eur J Immunol; 2013 Nov; 43(11):2875-85. PubMed ID: 23897063
[TBL] [Abstract][Full Text] [Related]
7. Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections.
Márquez-Coello M; Montes-de-Oca Arjona M; Fernández-Gutiérrez Del Álamo C; Ruiz-Sánchez C; Girón-González JA
Clin Exp Immunol; 2018 Dec; 194(3):350-360. PubMed ID: 30101536
[TBL] [Abstract][Full Text] [Related]
8. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
[TBL] [Abstract][Full Text] [Related]
9. Gut epithelial barrier and systemic inflammation during chronic HIV infection.
Somsouk M; Estes JD; Deleage C; Dunham RM; Albright R; Inadomi JM; Martin JN; Deeks SG; McCune JM; Hunt PW
AIDS; 2015 Jan; 29(1):43-51. PubMed ID: 25387317
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.
Jenabian MA; Patel M; Kema I; Vyboh K; Kanagaratham C; Radzioch D; Thébault P; Lapointe R; Gilmore N; Ancuta P; Tremblay C; Routy JP
Clin Exp Immunol; 2014 Oct; 178(1):102-11. PubMed ID: 24924152
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
[TBL] [Abstract][Full Text] [Related]
12. Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers.
Jenabian MA; Patel M; Kema I; Kanagaratham C; Radzioch D; Thébault P; Lapointe R; Tremblay C; Gilmore N; Ancuta P; Routy JP
PLoS One; 2013; 8(10):e78146. PubMed ID: 24147117
[TBL] [Abstract][Full Text] [Related]
13. T cell functionality in HIV-1, HIV-2 and dually infected individuals: correlates of disease progression and immune restoration.
Salwe S; Padwal V; Nagar V; Patil P; Patel V
Clin Exp Immunol; 2019 Nov; 198(2):233-250. PubMed ID: 31216050
[TBL] [Abstract][Full Text] [Related]
14. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
Schunter M; Chu H; Hayes TL; McConnell D; Crawford SS; Luciw PA; Bengmark S; Asmuth DM; Brown J; Bevins CL; Shacklett BL; Critchfield JW
BMC Complement Altern Med; 2012 Jun; 12():84. PubMed ID: 22747752
[TBL] [Abstract][Full Text] [Related]
15. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
Front Immunol; 2021; 12():688886. PubMed ID: 34135912
[TBL] [Abstract][Full Text] [Related]
16. Imbalances of gut-homing CD4+ T-cell subsets in HIV-1-infected Chinese patients.
Peng Q; Wang H; Wang H; Li X; Lu X; Liu L; Zhou B; Chen Z
J Acquir Immune Defic Syndr; 2013 Sep; 64(1):25-31. PubMed ID: 23572009
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells.
Prendergast A; Prado JG; Kang YH; Chen F; Riddell LA; Luzzi G; Goulder P; Klenerman P
AIDS; 2010 Feb; 24(4):491-502. PubMed ID: 20071976
[TBL] [Abstract][Full Text] [Related]
18. Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection Patients.
Ye J; Wang Y; Wang Z; Ji Q; Huang Y; Zeng T; Hu H; Ye D; Wan J; Lin Y
Mediators Inflamm; 2018; 2018():5697149. PubMed ID: 30258282
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.
Favre D; Mold J; Hunt PW; Kanwar B; Loke P; Seu L; Barbour JD; Lowe MM; Jayawardene A; Aweeka F; Huang Y; Douek DC; Brenchley JM; Martin JN; Hecht FM; Deeks SG; McCune JM
Sci Transl Med; 2010 May; 2(32):32ra36. PubMed ID: 20484731
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3 dioxygenase, age, and immune activation in people living with HIV.
Baer SL; Colombo RE; Johnson MH; Wakade S; Pacholczyk G; Newman-Whitlow C; Thompson SA; Saag MS; Martin JN; Floris-Moore M; Huang L; Mellor AL
J Investig Med; 2021 Aug; 69(6):1238-1244. PubMed ID: 33875612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
